Wave Life Sciences Taps Shire Finance Exec as CFO
Cambridge, MA-based RNA drug developer Wave Life Sciences (NASDAQ: WVE) has named Keith Regnante its chief financial officer. Regnante was previously the VP of finance at Shire, and had stints at Biogen and Boston Consulting Group before that.
More from EXOME
Trending on Xconomy
Underwriters and Partners
Xpertise: Watch + Learn
Sponsored · Whitepaper
Digitizing 10 Life Sciences Paper Processes
How to accelerate your life sciences business with every agreement
DocuSign
From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy
Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes